1492 Capital Management LLC - LIGAND PHARMACEUTICALS INC ownership

LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 332 filers reported holding LIGAND PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 2.08 and the average weighting 0.2%.

Quarter-by-quarter ownership
1492 Capital Management LLC ownership history of LIGAND PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2019$1,010,000
-15.7%
8,035
-9.0%
0.86%
-20.4%
Q4 2018$1,198,000
-54.0%
8,825
-7.1%
1.07%
-36.7%
Q3 2018$2,607,000
+31.6%
9,497
-0.7%
1.70%
+19.9%
Q2 2018$1,981,000
+23.5%
9,562
-1.5%
1.42%
+14.8%
Q1 2018$1,604,000
+20.6%
9,7120.0%1.23%
+18.9%
Q4 2017$1,330,000
-0.2%
9,712
-0.8%
1.04%
-12.0%
Q3 2017$1,333,000
+11.8%
9,790
-0.3%
1.18%
+12.2%
Q2 2017$1,192,000
+11.9%
9,820
-2.4%
1.05%
+26.9%
Q1 2017$1,065,000
+4.1%
10,0640.0%0.83%
+4.9%
Q4 2016$1,023,000
-59.1%
10,064
-59.0%
0.79%
-61.4%
Q3 2016$2,503,000
+361.0%
24,525
+438.3%
2.05%
+319.3%
Q2 2016$543,000
+1.1%
4,556
-9.2%
0.49%
+7.5%
Q1 2016$537,000
-4.6%
5,015
-3.4%
0.45%
+11.0%
Q4 2015$563,000
+16.1%
5,189
-8.4%
0.41%
+18.6%
Q3 2015$485,000
-89.4%
5,662
-90.4%
0.34%
-87.0%
Q1 2015$4,557,000
+288.5%
59,101
+168.2%
2.64%
+259.7%
Q4 2014$1,173,000
+11.5%
22,037
-1.5%
0.74%
+26.3%
Q3 2014$1,052,000
-32.7%
22,379
-10.9%
0.58%
-27.6%
Q2 2014$1,564,000
-9.7%
25,107
-2.5%
0.80%
-6.5%
Q1 2014$1,732,000
+41.9%
25,745
+10.9%
0.86%
+30.9%
Q4 2013$1,221,00023,2220.66%
Other shareholders
LIGAND PHARMACEUTICALS INC shareholders Q1 2019
NameSharesValueWeighting ↓
KNOTT DAVID M 353,041$36,819,00014.92%
CARDINAL CAPITAL MANAGEMENT LLC /CT 919,994$95,946,0002.93%
Elk Creek Partners, LLC 236,862$24,702,0002.84%
Conestoga Capital Advisors, LLC 619,653$64,624,0001.56%
WOODSTOCK CORP 71,489$7,456,0001.21%
Summit Creek Advisors LLC 70,962$7,401,0001.16%
FALCON POINT CAPITAL, LLC 8,115$846,0001.08%
RICE HALL JAMES & ASSOCIATES, LLC 302,503$31,548,0001.07%
Stephens Investment Management Group LLC 508,100$52,990,0001.00%
Tygh Capital Management, Inc. 55,672$5,806,0000.96%
View complete list of LIGAND PHARMACEUTICALS INC shareholders